Furthermore, the multivariate COX proportional hazard analysis of ccRCC patients with high PLOD2 expression indicated a poorer overall survival rate than those with low PLOD2 expression (HR = 2.455, p = 0.032, Fig. 3K, L). The gene discussed is PLOD2; the disease is nonpapillary renal cell carcinoma.